This is a table of adjective/noun combinations and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel.
adjective | noun | frequency |
---|---|---|
- | cell | 1299 |
immune | response | 986 |
- | analysis | 771 |
covid-19 | . | 707 |
immune | responses | 663 |
- | risk | 603 |
covid-19 | patients | 599 |
viral | infections | 533 |
- | time | 527 |
viral | infection | 495 |
high | risk | 439 |
immune | cells | 414 |
covid-19 | infection | 398 |
higher | risk | 329 |
inflammatory | response | 314 |
severe | disease | 313 |
- | cells | 308 |
humans | . | 298 |
respiratory | infections | 297 |
- | level | 284 |
high | levels | 250 |
respiratory | viruses | 247 |
covid-19 | cases | 242 |
severe | cases | 235 |
available | . | 229 |
- | protein | 223 |
significant | . | 221 |
respiratory | disease | 207 |
first | time | 203 |
- | year | 199 |
- | infection | 196 |
clinical | data | 186 |
higher | levels | 171 |
respiratory | infection | 167 |
- | group | 162 |
immune | cell | 161 |
clinical | studies | 158 |
- | treatment | 151 |
first | year | 151 |
other | studies | 149 |
older | age | 146 |
high | level | 134 |
respiratory | diseases | 128 |
chronic | diseases | 124 |
inflammatory | responses | 122 |
other | factors | 120 |
others | . | 118 |
viral | diseases | 115 |
older | patients | 114 |
low | levels | 113 |
positive | results | 113 |
- | day | 107 |
available | data | 107 |
positive | patients | 107 |
human | cells | 101 |
low | . | 101 |
old | . | 101 |
positive | . | 101 |
inflammatory | diseases | 99 |
severe | patients | 97 |
low | risk | 96 |
first | case | 95 |
human | disease | 94 |
high | expression | 93 |
- | expression | 90 |
covid-19 | disease | 90 |
chronic | disease | 89 |
inflammatory | disease | 86 |
- | years | 84 |
human | infection | 84 |
lower | levels | 84 |
important | . | 82 |
viral | proteins | 81 |
- | effects | 80 |
inflammatory | cells | 80 |
- | response | 79 |
high | . | 78 |
human | infections | 75 |
respiratory | virus | 74 |
inflammatory | effects | 71 |
other | viruses | 71 |
positive | cells | 71 |
first | study | 70 |
significant | risk | 69 |
common | . | 68 |
lower | risk | 68 |
new | cases | 67 |
clinical | study | 67 |
other | patients | 65 |
human | cases | 64 |
other | diseases | 63 |
- | infections | 61 |
other | . | 60 |
severe | infections | 60 |
highest | risk | 59 |
positive | cases | 59 |
important | factor | 58 |
- | age | 57 |
- | analyses | 57 |
- | patient | 56 |
first | day | 56 |
significant | effect | 55 |
- | days | 55 |
clinical | response | 55 |
- | aged | 52 |
viral | protein | 52 |
- | patients | 50 |
old | age | 50 |
viral | disease | 50 |
clinical | disease | 49 |
different | age | 49 |
higher | expression | 48 |
- | blood | 47 |
chronic | infection | 47 |
human | blood | 47 |
low | level | 46 |
human | cell | 46 |
- | disease | 46 |
positive | result | 45 |
- | virus | 45 |
specific | treatment | 44 |
different | levels | 43 |
higher | level | 43 |
human | diseases | 43 |
other | groups | 43 |
early | treatment | 42 |
inflammatory | effect | 42 |
other | infections | 42 |
such | cases | 42 |
positive | effect | 41 |
different | groups | 40 |
- | effect | 40 |
different | cell | 40 |
important | risk | 39 |
more | patients | 39 |
severe | . | 39 |
severe | infection | 39 |
acute | infection | 38 |
covid-19 | infections | 38 |
low | expression | 38 |
such | patients | 38 |
different | time | 36 |
other | genes | 36 |
positive | blood | 36 |
first | group | 35 |
- | groups | 34 |
high | blood | 34 |
positive | effects | 34 |
different | . | 34 |
earlier | studies | 33 |
other | cell | 33 |
human | studies | 32 |
higher | . | 31 |
human | . | 31 |
- | gene | 30 |
inflammatory | cell | 29 |
more | time | 29 |
new | virus | 29 |
other | age | 28 |
specific | effects | 28 |
different | studies | 28 |
early | studies | 28 |
- | case | 27 |
highest | levels | 27 |
other | cells | 27 |
other | proteins | 27 |
- | sars | 26 |
common | infections | 26 |
old | patient | 26 |
clinical | case | 25 |
first | cases | 25 |
specific | . | 24 |
other | risk | 24 |
significant | effects | 24 |
more | . | 24 |
more | studies | 24 |
covid-19 | case | 24 |
- | factor | 24 |
clinical | cases | 23 |
covid-19 | patient | 23 |
new | treatment | 23 |
specific | gene | 23 |
clinical | risk | 22 |
clinical | treatment | 22 |
covid-19 | treatment | 22 |
different | viruses | 22 |
first | patient | 22 |
severe | diseases | 21 |
specific | expression | 21 |
specific | cell | 21 |
inflammatory | factors | 21 |
lower | level | 21 |
human | patients | 21 |
chronic | infections | 21 |
covid-19 | risk | 20 |
different | blood | 20 |
different | times | 20 |
larger | studies | 20 |
older | . | 20 |
severe | sars | 20 |
specific | genes | 20 |
viral | gene | 20 |
other | cases | 19 |
other | day | 19 |
- | study | 19 |
new | infections | 19 |
important | factors | 19 |
acute | infections | 18 |
early | data | 18 |
inflammatory | gene | 18 |
severe | group | 18 |
specific | risk | 18 |
such | studies | 17 |
specific | data | 17 |
other | patient | 17 |
other | disease | 17 |
new | data | 17 |
large | group | 17 |
immune | genes | 17 |
higher | case | 17 |
first | . | 17 |
early | disease | 17 |
clinical | factors | 17 |
- | data | 16 |
clinical | analysis | 16 |
common | infection | 16 |
lower | . | 16 |
other | blood | 16 |
specific | responses | 15 |
specific | disease | 15 |
more | cases | 15 |
such | data | 15 |
more | data | 15 |
common | risk | 15 |
human | data | 15 |
- | studied | 15 |
clinical | effects | 15 |
different | treatment | 15 |
different | diseases | 14 |
specific | treatments | 14 |
low | blood | 14 |
larger | study | 14 |
early | . | 14 |
different | disease | 14 |
covid-19 | virus | 14 |
common | diseases | 14 |
clinical | effect | 14 |
human | genes | 13 |
severe | case | 13 |
other | study | 13 |
new | blood | 13 |
larger | patient | 13 |
different | ages | 13 |
highest | level | 13 |
different | risk | 13 |
different | genes | 13 |
- | levels | 13 |
other | data | 12 |
specific | infection | 12 |
specific | factors | 12 |
significant | factor | 12 |
positive | group | 12 |
other | treatment | 12 |
new | disease | 12 |
first | days | 12 |
early | age | 12 |
different | factors | 12 |
common | disease | 12 |
highest | expression | 12 |
new | patients | 11 |
large | studies | 11 |
such | diseases | 11 |
specific | proteins | 11 |
significant | results | 11 |
significant | factors | 11 |
other | virus | 11 |
inflammatory | protein | 11 |
inflammatory | genes | 11 |
human | viruses | 11 |
human | proteins | 11 |
high | case | 11 |
different | study | 11 |
acute | disease | 11 |
significant | group | 10 |
large | cell | 10 |
positive | response | 10 |
first | years | 10 |
specific | protein | 10 |
viral | genes | 10 |
large | . | 10 |
lower | infection | 10 |
early | infection | 10 |
different | cells | 10 |
- | factors | 10 |
covid-19 | data | 10 |
clinical | results | 10 |
acute | effects | 10 |
- | proteins | 10 |
different | effects | 10 |
large | effect | 9 |
specific | virus | 9 |
specific | patient | 9 |
significant | level | 9 |
positive | patient | 9 |
other | treatments | 9 |
new | studies | 9 |
lower | expression | 9 |
new | diseases | 9 |
immune | factors | 9 |
clinical | infection | 9 |
higher | infection | 9 |
higher | age | 9 |
earlier | study | 9 |
different | results | 9 |
different | patients | 9 |
covid-19 | response | 9 |
higher | risks | 9 |
new | viruses | 8 |
old | patients | 8 |
positive | case | 8 |
positive | disease | 8 |
positive | expression | 8 |
viral | response | 8 |
positive | sars | 8 |
positives | . | 8 |
significant | expression | 8 |
viral | responses | 8 |
more | years | 8 |
new | treatments | 8 |
high | infection | 8 |
more | risk | 8 |
high | group | 8 |
important | protein | 8 |
available | studies | 8 |
covid-19 | responses | 8 |
first | blood | 8 |
early | protein | 8 |
human | case | 8 |
human | gene | 8 |
human | sars | 8 |
immune | effects | 8 |
immune | diseases | 7 |
large | study | 7 |
new | genes | 7 |
new | infection | 7 |
other | group | 7 |
significant | disease | 7 |
viral | factors | 7 |
specific | diseases | 7 |
specific | studies | 7 |
such | effect | 7 |
such | effects | 7 |
viral | group | 7 |
important | data | 7 |
different | virus | 7 |
human | virus | 7 |
different | proteins | 7 |
human | protein | 7 |
available | treatment | 7 |
different | days | 7 |
different | expression | 7 |
different | group | 7 |
- | genes | 7 |
early | days | 7 |
early | time | 7 |
high | protein | 7 |
higher | disease | 7 |
early | results | 7 |
other | sars | 6 |
more | times | 6 |
other | case | 6 |
other | effects | 6 |
other | gene | 6 |
specific | infections | 6 |
specific | analysis | 6 |
specific | groups | 6 |
specific | viruses | 6 |
such | treatment | 6 |
inflammatory | factor | 6 |
more | days | 6 |
new | gene | 6 |
important | disease | 6 |
different | response | 6 |
human | patient | 6 |
acute | treatment | 6 |
available | blood | 6 |
chronic | treatment | 6 |
different | patient | 6 |
chronic | . | 6 |
earlier | time | 6 |
early | years | 6 |
first | treatment | 6 |
high | response | 6 |
other | infection | 5 |
large | patient | 5 |
large | virus | 5 |
important | diseases | 5 |
lowest | risk | 5 |
more | viruses | 5 |
older | ages | 5 |
older | group | 5 |
specific | group | 5 |
positive | cell | 5 |
respiratory | cells | 5 |
significant | infections | 5 |
specific | case | 5 |
specific | cells | 5 |
specific | response | 5 |
such | cells | 5 |
such | infections | 5 |
immune | gene | 5 |
immune | proteins | 5 |
first | results | 5 |
higher | virus | 5 |
common | viruses | 5 |
higher | blood | 5 |
- | diseases | 5 |
- | results | 5 |
acute | cases | 5 |
chronic | effects | 5 |
clinical | diseases | 5 |
clinical | patient | 5 |
common | factor | 5 |
- | viruses | 5 |
different | gene | 5 |
different | treatments | 5 |
early | study | 5 |
first | infection | 5 |
high | disease | 5 |
high | patient | 5 |
different | responses | 5 |
high | virus | 5 |
lower | age | 4 |
more | blood | 4 |
large | effects | 4 |
lower | responses | 4 |
lower | patient | 4 |
lower | blood | 4 |
largest | study | 4 |
low | infection | 4 |
low | group | 4 |
largest | group | 4 |
largest | effect | 4 |
new | case | 4 |
more | infections | 4 |
specific | blood | 4 |
new | sars | 4 |
old | disease | 4 |
older | groups | 4 |
other | results | 4 |
significant | blood | 4 |
significant | data | 4 |
significant | genes | 4 |
significant | levels | 4 |
significant | risks | 4 |
such | analyses | 4 |
such | analysis | 4 |
viral | . | 4 |
viral | factor | 4 |
largest | case | 4 |
early | times | 4 |
large | data | 4 |
early | effect | 4 |
large | blood | 4 |
- | . | 4 |
acute | virus | 4 |
clinical | . | 4 |
clinical | expression | 4 |
common | cases | 4 |
common | treatment | 4 |
covid-19 | group | 4 |
covid-19 | study | 4 |
earlier | treatment | 4 |
early | analysis | 4 |
early | case | 4 |
clinical | responses | 4 |
early | expression | 4 |
human | study | 4 |
early | gene | 4 |
inflammatory | treatments | 4 |
inflammatory | treatment | 4 |
inflammatory | . | 4 |
inflammatory | proteins | 4 |
higher | response | 4 |
high | risks | 4 |
first | studies | 4 |
early | responses | 4 |
early | response | 4 |
new | risk | 3 |
lower | disease | 3 |
new | proteins | 3 |
new | . | 3 |
more | groups | 3 |
more | genes | 3 |
more | disease | 3 |
lower | group | 3 |
large | protein | 3 |
lower | case | 3 |
low | case | 3 |
larger | virus | 3 |
larger | groups | 3 |
larger | data | 3 |
large | gene | 3 |
old | diseases | 3 |
new | risks | 3 |
such | proteins | 3 |
old | group | 3 |
older | blood | 3 |
viral | cell | 3 |
such | study | 3 |
such | results | 3 |
important | treatment | 3 |
such | factors | 3 |
specific | study | 3 |
specific | risks | 3 |
specific | effect | 3 |
specific | age | 3 |
significant | infection | 3 |
severe | risk | 3 |
other | time | 3 |
other | risks | 3 |
other | analyses | 3 |
older | patient | 3 |
important | viruses | 3 |
more | treatment | 3 |
important | infection | 3 |
clinical | gene | 3 |
different | data | 3 |
different | case | 3 |
covid-19 | effects | 3 |
common | genes | 3 |
common | factors | 3 |
common | blood | 3 |
common | age | 3 |
anti | factor | 3 |
different | protein | 3 |
acute | sars | 3 |
acute | blood | 3 |
- | times | 3 |
- | risks | 3 |
- | responses | 3 |
- | diseased | 3 |
immune | risk | 3 |
different | effect | 3 |
acute | response | 3 |
different | sars | 3 |
higher | cell | 3 |
immune | . | 3 |
earlier | age | 3 |
human | response | 3 |
human | factors | 3 |
highest | . | 3 |
higher | treatment | 3 |
higher | patient | 3 |
human | expression | 3 |
higher | % | 3 |
early | genes | 3 |
early | proteins | 3 |
early | infections | 3 |
earlier | years | 3 |
early | group | 3 |
first | disease | 3 |
new | level | 2 |
new | patient | 2 |
new | protein | 2 |
new | results | 2 |
new | study | 2 |
newer | treatment | 2 |
newer | studies | 2 |
old | ages | 2 |
old | cases | 2 |
oldest | age | 2 |
new | cells | 2 |
older | studies | 2 |
new | group | 2 |
more | analyses | 2 |
more | study | 2 |
more | results | 2 |
more | patient | 2 |
more | gene | 2 |
more | factors | 2 |
more | case | 2 |
lowest | expression | 2 |
lowest | . | 2 |
low | virus | 2 |
low | response | 2 |
other | analysis | 2 |
low | patients | 2 |
oldest | patients | 2 |
such | responses | 2 |
other | protein | 2 |
specific | sars | 2 |
largest | age | 2 |
viral | treatment | 2 |
viral | studies | 2 |
viral | expression | 2 |
viral | cases | 2 |
viral | analysis | 2 |
such | viruses | 2 |
such | time | 2 |
such | risks | 2 |
such | groups | 2 |
specific | times | 2 |
specific | cases | 2 |
other | times | 2 |
specific | analyses | 2 |
significant | treatment | 2 |
significant | time | 2 |
significant | response | 2 |
significant | cell | 2 |
significant | age | 2 |
severe | response | 2 |
respiratory | level | 2 |
respiratory | factors | 2 |
respiratory | effects | 2 |
other | year | 2 |
low | disease | 2 |
lower | % | 2 |
larger | viruses | 2 |
clinical | patients | 2 |
first | patients | 2 |
first | data | 2 |
first | analysis | 2 |
early | sars | 2 |
early | effects | 2 |
early | blood | 2 |
different | infections | 2 |
covid-19 | sars | 2 |
covid-19 | results | 2 |
common | virus | 2 |
common | gene | 2 |
clinical | treatments | 2 |
clinical | infections | 2 |
high | age | 2 |
clinical | group | 2 |
chronic | blood | 2 |
available | expression | 2 |
available | cases | 2 |
available | case | 2 |
- | treatments | 2 |
- | studies | 2 |
- | result | 2 |
- | et | 2 |
- | al | 2 |
- | ageing | 2 |
larger | proteins | 2 |
first | sars | 2 |
- | aging | 2 |
high | cases | 2 |
important | group | 2 |
high | cell | 2 |
larger | group | 2 |
larger | patients | 2 |
larger | age | 2 |
large | groups | 2 |
large | factor | 2 |
large | case | 2 |
inflammatory | blood | 2 |
important | studies | 2 |
important | patient | 2 |
important | infections | 2 |
inflammatory | expression | 2 |
important | effect | 2 |
human | aging | 2 |
high | groups | 2 |
higher | protein | 2 |
important | blood | 2 |
highest | data | 2 |
highest | disease | 2 |
highest | age | 2 |
human | factor | 2 |
immune | disease | 2 |
immune | effect | 2 |
immune | studies | 2 |
lower | groups | 1 |
more | cells | 1 |
lower | patients | 1 |
lower | response | 1 |
lower | results | 1 |
lower | risks | 1 |
lower | treatment | 1 |
lower | virus | 1 |
lowest | level | 1 |
lowest | levels | 1 |
lowest | protein | 1 |
more | cell | 1 |
newer | disease | 1 |
more | factor | 1 |
more | protein | 1 |
more | sars | 1 |
more | treatments | 1 |
new | age | 1 |
new | analyses | 1 |
new | analysis | 1 |
new | cell | 1 |
newer | cases | 1 |
newer | data | 1 |
old | cells | 1 |
old | studies | 1 |
lower | cell | 1 |
largest | blood | 1 |
lowed | level | 1 |
low | treatment | 1 |
important | cells | 1 |
olds | . | 1 |
important | day | 1 |
important | genes | 1 |
important | results | 1 |
inflammatory | age | 1 |
inflammatory | group | 1 |
inflammatory | levels | 1 |
inflammatory | patients | 1 |
inflammatory | risk | 1 |
large | genes | 1 |
large | proteins | 1 |
larger | blood | 1 |
larger | case | 1 |
larger | protein | 1 |
largest | gene | 1 |
largest | patient | 1 |
largest | studies | 1 |
low | % | 1 |
low | age | 1 |
low | cells | 1 |
low | gene | 1 |
low | patient | 1 |
low | responses | 1 |
low | result | 1 |
older | study | 1 |
significant | result | 1 |
other | ages | 1 |
such | gene | 1 |
specific | level | 1 |
specific | levels | 1 |
specific | patients | 1 |
specific | results | 1 |
such | . | 1 |
such | age | 1 |
such | blood | 1 |
such | case | 1 |
such | cell | 1 |
such | disease | 1 |
such | factor | 1 |
such | infection | 1 |
specific | day | 1 |
such | protein | 1 |
such | result | 1 |
such | risk | 1 |
such | times | 1 |
such | treatments | 1 |
such | virus | 1 |
viral | effect | 1 |
viral | effects | 1 |
viral | levels | 1 |
viral | risk | 1 |
important | cases | 1 |
specific | days | 1 |
significant | studies | 1 |
other | levels | 1 |
respiratory | data | 1 |
other | studied | 1 |
others | groups | 1 |
others | patients | 1 |
positive | gene | 1 |
positive | infection | 1 |
positive | infections | 1 |
positive | responses | 1 |
positive | risk | 1 |
positive | studies | 1 |
positives | cells | 1 |
respiratory | cases | 1 |
respiratory | responses | 1 |
significant | responses | 1 |
respiratory | study | 1 |
severe | blood | 1 |
severe | cell | 1 |
severe | effects | 1 |
severe | patient | 1 |
severe | treatment | 1 |
severe | virus | 1 |
severest | cases | 1 |
significant | case | 1 |
significant | day | 1 |
significant | patient | 1 |
important | cell | 1 |
acute | groups | 1 |
immune | treatments | 1 |
immune | study | 1 |
common | case | 1 |
common | cell | 1 |
common | data | 1 |
common | group | 1 |
common | groups | 1 |
common | level | 1 |
common | proteins | 1 |
common | responses | 1 |
common | sars | 1 |
commonest | . | 1 |
commonest | gene | 1 |
commonest | infections | 1 |
commonest | virus | 1 |
covid-19 | diseases | 1 |
covid-19 | effect | 1 |
covid-19 | expression | 1 |
covid-19 | groups | 1 |
covid-19 | risks | 1 |
covid-19 | treatments | 1 |
different | expressions | 1 |
different | infection | 1 |
different | level | 1 |
different | risks | 1 |
earlier | analyses | 1 |
earlier | data | 1 |
clinical | levels | 1 |
clinical | level | 1 |
clinical | groups | 1 |
available | factor | 1 |
- | ages | 1 |
- | cases | 1 |
acute | . | 1 |
acute | case | 1 |
acute | group | 1 |
acute | patients | 1 |
acute | viruses | 1 |
anti | infection | 1 |
anti | virus | 1 |
available | cells | 1 |
available | day | 1 |
available | patients | 1 |
clinical | expressions | 1 |
available | protein | 1 |
available | response | 1 |
available | risk | 1 |
available | treatments | 1 |
available | virus | 1 |
chronic | age | 1 |
chronic | groups | 1 |
chronic | patients | 1 |
chronic | response | 1 |
chronic | virus | 1 |
clinical | blood | 1 |
earlier | disease | 1 |
earlier | infection | 1 |
earlier | treatments | 1 |
human | group | 1 |
higher | effects | 1 |
higher | gene | 1 |
higher | patients | 1 |
higher | responses | 1 |
higher | sars | 1 |
highest | blood | 1 |
highest | case | 1 |
highest | protein | 1 |
highest | risks | 1 |
highest | time | 1 |
highest | virus | 1 |
human | levels | 1 |
high | treatment | 1 |
human | responses | 1 |
humans | aging | 1 |
humans | case | 1 |
humans | cases | 1 |
humans | effects | 1 |
humans | resulted | 1 |
humans | resulting | 1 |
humans | studied | 1 |
humans | studies | 1 |
immune | aging | 1 |
immune | patients | 1 |
higher | day | 1 |
high | patients | 1 |
earlier | virus | 1 |
early | patients | 1 |
earliest | . | 1 |
earliest | case | 1 |
earliest | cases | 1 |
earliest | patient | 1 |
earliest | studies | 1 |
early | aging | 1 |
early | analyses | 1 |
early | cases | 1 |
early | factors | 1 |
early | level | 1 |
early | patient | 1 |
early | risk | 1 |
high | effect | 1 |
early | treatments | 1 |
early | virus | 1 |
first | cell | 1 |
first | diseased | 1 |
first | expression | 1 |
first | gene | 1 |
first | grouped | 1 |
first | level | 1 |
first | treatments | 1 |
first | viruses | 1 |
high | cells | 1 |
viral | sars | 1 |